Moderna (MRNA) Confirms Publication in NEJM of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 - StreetInsider.com
Moderna (MRNA) Confirms Publication in NEJM of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 StreetInsider.com
Comments
Post a Comment